CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Current Deferred Revenue : $0.03 Mil (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

CTT Pharmaceutical Holdings's current deferred revenue for the quarter that ended in Jun. 2018 was $0.03 Mil.

CTT Pharmaceutical Holdings Current Deferred Revenue Historical Data

The historical data trend for CTT Pharmaceutical Holdings's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings Current Deferred Revenue Chart

CTT Pharmaceutical Holdings Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Current Deferred Revenue

Get a 7-Day Free Trial

CTT Pharmaceutical Holdings Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Mar17	Jun17	Mar18	Jun18
Current Deferred Revenue	Get a 7-Day Free Trial															0.03	-	-	0.03	0.03

CTT Pharmaceutical Holdings Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6

Website

https://www.cttpharmaceuticals.com

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.

Executives